197 related articles for article (PubMed ID: 16678551)
1. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
[TBL] [Abstract][Full Text] [Related]
2. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition.
Tank J; Schroeder C; Diedrich A; Szczech E; Haertter S; Sharma AM; Luft FC; Jordan J
Circulation; 2003 Jun; 107(23):2949-54. PubMed ID: 12796139
[TBL] [Abstract][Full Text] [Related]
3. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
4. Sympathetic vasomotor tone determines blood pressure response to long-term sibutramine treatment.
Heusser K; Engeli S; Tank J; Diedrich A; Wiesner S; Janke J; Luft FC; Jordan J
J Clin Endocrinol Metab; 2007 Apr; 92(4):1560-3. PubMed ID: 17284621
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
Daniels SR; Long B; Crow S; Styne D; Sothern M; Vargas-Rodriguez I; Harris L; Walch J; Jasinsky O; Cwik K; Hewkin A; Blakesley V;
Pediatrics; 2007 Jul; 120(1):e147-57. PubMed ID: 17576783
[TBL] [Abstract][Full Text] [Related]
6. Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.
Jordan J; Scholze J; Matiba B; Wirth A; Hauner H; Sharma AM
Int J Obes (Lond); 2005 May; 29(5):509-16. PubMed ID: 15685250
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
Birkenfeld AL; Schroeder C; Pischon T; Tank J; Luft FC; Sharma AM; Jordan J
Clin Auton Res; 2005 Jun; 15(3):200-6. PubMed ID: 15944869
[TBL] [Abstract][Full Text] [Related]
8. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical effect of sibutramine on autonomic cardiovascular regulation.
Birkenfeld AL; Schroeder C; Boschmann M; Tank J; Franke G; Luft FC; Biaggioni I; Sharma AM; Jordan J
Circulation; 2002 Nov; 106(19):2459-65. PubMed ID: 12417543
[TBL] [Abstract][Full Text] [Related]
10. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives.
Abrahão SB; Tinucci T; Santello JL; Mion D
J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465
[TBL] [Abstract][Full Text] [Related]
11. The effect of sibutramine intake on resting and exercise physiological responses.
Rotstein A; Inbar O; Vaisman N
Ann Nutr Metab; 2008; 52(1):17-23. PubMed ID: 18230966
[TBL] [Abstract][Full Text] [Related]
12. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
Ruzicka M; Coletta E; Leenen FH
Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans.
Heindl S; Holzschneider J; Hinz A; Sayk F; Fehm HL; Dodt C
J Neuroendocrinol; 2006 Feb; 18(2):115-21. PubMed ID: 16420280
[TBL] [Abstract][Full Text] [Related]
14. Baroreflex regulation of heart rate and sympathetic vasomotor tone in women and men.
Tank J; Diedrich A; Szczech E; Luft FC; Jordan J
Hypertension; 2005 Jun; 45(6):1159-64. PubMed ID: 15867130
[TBL] [Abstract][Full Text] [Related]
15. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
Di Francesco V; Sacco T; Zamboni M; Bissoli L; Zoico E; Mazzali G; Minniti A; Salanitri T; Cancelli F; Bosello O
Ann Nutr Metab; 2007; 51(1):75-81. PubMed ID: 17356258
[TBL] [Abstract][Full Text] [Related]
16. Acute beta-blockade increases muscle sympathetic activity and modifies its frequency distribution.
Cogliati C; Colombo S; Ruscone TG; Gruosso D; Porta A; Montano N; Malliani A; Furlan R
Circulation; 2004 Nov; 110(18):2786-91. PubMed ID: 15505096
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of hydrocortisone on sympathetic and hemodynamic responses to sympathoexcitatory manoeuvres in men.
Heindl S; Vahlkamp K; Weitz G; Fehm HL; Dodt C
Steroids; 2006 Mar; 71(3):206-13. PubMed ID: 16388832
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
[TBL] [Abstract][Full Text] [Related]
19. Effect of pimobendan on cardiopulmonary baroreflex control of sympathetic nerve activity in healthy young men.
Maruyama M; Takamura M; Takata S; Murai H; Usui S; Furusho H; Sakagami S; Yuasa T; Shimakura A; Kaneko S
Auton Neurosci; 2005 Oct; 122(1-2):100-6. PubMed ID: 16199209
[TBL] [Abstract][Full Text] [Related]
20. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea.
Yee BJ; Phillips CL; Banerjee D; Caterson I; Hedner JA; Grunstein RR
Int J Obes (Lond); 2007 Jan; 31(1):161-8. PubMed ID: 16652122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
